{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:07:39Z","timestamp":1761919659431,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1053\/j.ajkd.2012.11.049","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T07:06:43Z","timestamp":1359702403000},"page":"786-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy"],"prefix":"10.1053","volume":"61","author":[{"given":"Manuel","family":"Wallbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman J.","family":"Gr\u00f6ne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Kitze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Koziolek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ajkd.2012.11.049_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2012.11.049_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000057631","article-title":"Immune-mediated complications during interferon therapy in hematological patients","volume":"107","author":"Raanani","year":"2002","journal-title":"Acta Haematol"},{"issue":"2","key":"10.1053\/j.ajkd.2012.11.049_bib3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s10067-004-1024-2","article-title":"Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C","volume":"24","author":"Niewold","year":"2005","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1053\/j.ajkd.2012.11.049_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00296-006-0198-0","article-title":"Full-house nephropathy in a patient with negative serology for lupus","volume":"27","author":"Baskin","year":"2007","journal-title":"Rheumatol Int"},{"issue":"1-2","key":"10.1053\/j.ajkd.2012.11.049_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2011.09.032","article-title":"Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis","volume":"313","author":"Feng","year":"2012","journal-title":"J Neurol Sci"},{"issue":"9","key":"10.1053\/j.ajkd.2012.11.049_bib6","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/art.34483","article-title":"Large-scale analysis of tumor necrosis factor \u03b1 levels in systemic lupus erythematosus","volume":"64","author":"Weckerle","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1053\/j.ajkd.2012.11.049_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/08916930310001605873","article-title":"Induction of clinical autoimmune disease by therapeutic interferon-alpha","volume":"36","author":"Gota","year":"2003","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1053\/j.ajkd.2012.11.049_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0961203308093550","article-title":"Anti-double stranded DNA and lupus syndrome induced by interferon-\u03b2 therapy in a patient with multiple sclerosis","volume":"18","author":"Bonaci-Nikolic","year":"2009","journal-title":"Lupus"},{"issue":"3","key":"10.1053\/j.ajkd.2012.11.049_bib9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1172\/JCI119571","article-title":"Microglial production of TNF alpha is induced by activated T lymphocytes","volume":"100","author":"Chabot","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1053\/j.ajkd.2012.11.049_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(99)00029-6","article-title":"Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers","volume":"99","author":"Rothuizen","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.11.049_bib11","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1212\/WNL.46.6.1633","article-title":"Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis","volume":"46","author":"Brod","year":"1996","journal-title":"Neurology"},{"issue":"2","key":"10.1053\/j.ajkd.2012.11.049_bib12","first-page":"329","article-title":"Delay in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period","volume":"95","author":"Gresser","year":"1979","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.11.049_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20021996","article-title":"Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice","volume":"197","author":"Santiago-Raber","year":"2003","journal-title":"J Exp Med"},{"issue":"4","key":"10.1053\/j.ajkd.2012.11.049_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semnephrol.2011.06.005","article-title":"Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification","volume":"31","author":"Sethi","year":"2011","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2012.11.049_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2012.11.049_bib16","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1681\/ASN.2006101104","article-title":"Interferon-beta reduces proteinuria in experimental glomerulonephritis","volume":"18","author":"Satchell","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2012.11.049_bib17","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1681\/ASN.2004111014","article-title":"Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice","volume":"16","author":"Schwarting","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612015831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612015831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:06:31Z","timestamp":1759457191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638612015831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0272638612015831"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.11.049","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephrotic Syndrome in a Multiple Sclerosis Patient Receiving Long-term Interferon Beta Therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.11.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}